(Q46115563)

19 December 2017

meta-analysis

0 references

title

Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets (English)

1 reference

19 December 2017

author name string

Eleftherios C Vamvakas

series ordinal

1

1 reference

19 December 2017

publication date

8 November 2010

1 reference

19 December 2017

published in

Transfusion

1 reference

19 December 2017

volume

51

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

1058-1071

1 reference

19 December 2017

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Pathogen inactivation: a new paradigm for blood safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Dose of prophylactic platelet transfusions and prevention of hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

A systematic assessment of the quality of reporting for platelet transfusion studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

In vivo and in vitro comparison of platelets stored in either synthetic media or plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Platelet storage for 7 days in second-generation blood bags

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Influence of clinical status on the efficiency of stored platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Factors influencing 20-hour increments after platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Guidelines for the use of platelet transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Platelet ADP response deteriorates in synthetic storage media

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

Pathogen inactivation of platelet concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02925.X

10.1111/J.1537-2995.2010.02925.X

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017